Intercytex raises L12 million

Cell therapy company Intercytex (Cambridge, U.K.) raised L12 million ($21.1 million) in a series D round. Existing investors Avlar BioVentures; Merlin Biosciences; 3i; Cambridge Gateway; NIF Ventures;...